Harrow Health (HROW) Earnings Analysis
Harrow Health (HROW) next reports earnings on 2026-08-10, consensus EPS -0.23 USD. Last quarter (2026-05-11) it missed with EPS -0.74 USD vs -0.43 USD est (-72.1%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -109.12.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HROW next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.23 USD |
| Revenue estimate | 0.07B |
HROW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.74 USD | -0.43 USD | -72.1% | Miss |
| 2026-03-02 | 0.26 USD | 0.4 USD | -35% | Miss |
| 2025-11-10 | 0.33 USD | 0.22 USD | +50% | Beat |
| 2025-08-11 | 0.24 USD | 0.3133 USD | -23.4% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
HROW valuation and analyst view
| Trailing P/E | -109.12 |
|---|---|
| Trailing EPS | -0.40184 USD |
| Price / book | 55.55 |
| Dividend yield | 0.00% |
| Market cap | 1.62B |
| Analyst consensus | Buy (10 buy / 0 hold / 0 sell) |
| Avg price target | 88 USD |
Related research pages
Frequently asked questions
When is Harrow Health (HROW)'s next earnings date?
Harrow Health is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.23 USD and revenue estimate of 0.07B.
Did HROW beat earnings last quarter?
In its 2026-05-11 report, HROW posted EPS of -0.74 USD versus a -0.43 USD estimate — a miss of 72.1%.
What is HROW's earnings track record?
Over the last 4 reported quarters with consensus data, HROW beat estimates 1 times (25%).
What is HROW's current P/E ratio and EPS?
HROW trades at a trailing P/E of -109.12 on trailing EPS of -0.4018390859674305 USD.
What do analysts rate HROW?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 88 USD.